Development of high affinity broadly reactive aptamers for spike protein of multiple SARS-CoV-2 variants
Description
We have developed broadly reactive aptamers against multiple variants by alternating the target between spike proteins from different SARS-CoV-2 variants during the selection process. In this process we have developed aptamers which can recognise all
